Kolumne, ORE

Original-Research: MHP Hotel AG - from NuWays AG 13.06.2025 / 09:00 CET / CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.

13.06.2025 - 09:00:36

Original-Research: MHP Hotel AG (von NuWays AG): Buy

Original-Research: MHP Hotel AG - from NuWays AG

13.06.2025 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS
Group.
The issuer is solely responsible for the content of this research. The
result of this research does not constitute investment advice or an
invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to MHP Hotel AG

     Company Name:                MHP Hotel AG
     ISIN:                        DE000A3E5C24

     Reason for the research:     Update
     Recommendation:              Buy
     from:                        13.06.2025
     Target price:                EUR 3.00
     Target price on sight of:    12 months
     Last rating change:
     Analyst:                     Phillipp Sennewald

Strong FY24 no surprise after guidance hike, chg.

Y24 sales increased by 18.2% yoy to EUR 161m (eNuW: EUR 160m), carried by both
F&B (+17.1% to EUR 32.2m) as well as Logis (+18.6% to EUR 122.7m) sales.
Overall, the strong increase in Logis sales is a result of improved
occupancy (+5.6pp to 77.5%) as well as an increased ADR of EUR 217.75 (+6.5%
yoy), which led to a strongly improved RevPar of EUR 168.73 (+14.8% yoy).
While the wave of big events and concerts (UEFA Euro, Adele concerts, etc.)
surely had its impact on occupancy, especially the continuously improving
ADR underscores MHP's price leadership. Mind you, that the company has by
far the highest ADR's of all hotel companies in Germany.

On this basis, FY24 EBITDA substantially improved from EUR 1.1m in FY23 (EUR 4m
adj.) to EUR 10.4m in FY24, implying a margin of 6.4%. In our view, this was
predominantly caused by positive operating leverage. Notably, the company's
own brand MOOONS (1 hotel in Vienna) achieved a strong result with an EBITDA
margin of 11%.

Against the backdrop of a good start into the year (see Theme part of our
initiation), management again confirmed the FY guidance of EUR 180m sales
(eNuW: EUR 185.3m) and EUR 15m EBITDA (eNuW: EUR 15.3m/ EUR 10.3m adj. EBITDA excl.
key-money payments), implying a 15% yoy top-line increase and an 8.3% EBITDA
margin.

Expansion as potential catalyst. As stated before, CEO Frehse once again
highlighted that the current market situation offers some appealing
investment opportunities for MHP. As some peers have struggled recently,
options for MHP to take over and reposition hotels in prominent locations
should become available. Here, the company in yesterday's corporate news
reiterated that is currently observing several options to increase existing
financing capabilities in order to be more flexible. Mind you, that we do
not include any portfolio expansion in our model, thus leaving some upside
to our estimates.

Overall, the release fully underpins our conviction in the case as MHP again
proved the financial resilience and strength of its positioning in the
luxury hotel segment.

We thus confirm BUY with an unchanged PT of EUR 3.00 based on DCF.

You can download the research here: http://www.more-ir.de/d/32850.pdf
For additional information visit our website:
https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss
bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben
analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

2154664 13.06.2025 CET/CEST

@ dpa.de

Weitere Meldungen

Original-Research: Wolftank Group AG (von Montega AG): Kaufen Original-Research: Wolftank Group AG - von Montega AG 12.06.2025 / 18:03 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. (Boerse, 12.06.2025 - 18:03) weiterlesen...

Original-Research: Marinomed Biotech AG (von GBC AG): Kaufen Original-Research: Marinomed Biotech AG - von GBC AG 12.06.2025 / 14:00 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. (Boerse, 12.06.2025 - 14:00) weiterlesen...

Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy. - from Sphene Capital GmbH 12.06.2025 / 12:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. Original-Research: Almonty Industries Inc. (Boerse, 12.06.2025 - 12:39) weiterlesen...

Original-Research: PORR AG (von Montega AG): Kaufen Original-Research: PORR AG - von Montega AG 11.06.2025 / 16:47 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. (Boerse, 11.06.2025 - 16:47) weiterlesen...

Original-Research: ÖKOWORLD AG (von BankM AG): Kaufen Original-Research: ÖKOWORLD AG - von BankM AG 11.06.2025 / 16:19 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. (Boerse, 11.06.2025 - 16:19) weiterlesen...

Original-Research: Swissnet AG (formerly Beaconsmind AG) (von First Berlin Eq... Original-Research: Swissnet AG (formerly Beaconsmind AG) - from First Berlin Equity Research GmbH 11.06.2025 / 14:41 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. (Boerse, 11.06.2025 - 14:41) weiterlesen...